Expert-level segmentation using deep learning for volumetry of polycystic kidney and liver
- PMID: 33135401
- PMCID: PMC7606119
- DOI: 10.4111/icu.20200086
Expert-level segmentation using deep learning for volumetry of polycystic kidney and liver
Abstract
Purpose: Volumetry is used in polycystic kidney and liver diseases (PKLDs), including autosomal dominant polycystic kidney disease (ADPKD), to assess disease progression and drug efficiency. However, since no rapid and accurate method for volumetry has been developed, volumetry has not yet been established in clinical practice, hindering the development of therapies for PKLD. This study presents an artificial intelligence (AI)-based volumetry method for PKLD.
Materials and methods: The performance of AI was first evaluated in comparison with ground-truth (GT). We trained a V-net-based convolutional neural network on 175 ADPKD computed tomography (CT) segmentations, which served as the GT and were agreed upon by 3 experts using images from 214 patients analyzed with volumetry. The dice similarity coefficient (DSC), interobserver correlation coefficient (ICC), and Bland-Altman plots of 39 GT and AI segmentations in the validation set were compared. Next, the performance of AI on the segmentation of 50 random CT images was compared with that of 11 PKLD specialists based on the resulting DSC and ICC.
Results: The DSC and ICC of the AI were 0.961 and 0.999729, respectively. The error rate was within 3% for approximately 95% of the CT scans (error<1%, 46.2%; 1%≤error<3%, 48.7%). Compared with the specialists, AI showed moderate performance. Furthermore, an outlier in our results confirmed that even PKLD specialists can make mistakes in volumetry.
Conclusions: PKLD volumetry using AI was fast and accurate. AI performed comparably to human specialists, suggesting its use may be practical in clinical settings.
Keywords: Artificial intelligence; Polycystic kidney diseases; Tomography.
© The Korean Urological Association, 2020.
Conflict of interest statement
The authors have nothing to disclose.
Figures





Similar articles
-
Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease.Investig Clin Urol. 2023 May;64(3):255-264. doi: 10.4111/icu.20220411. Investig Clin Urol. 2023. PMID: 37341005 Free PMC article.
-
Polycystic liver: automatic segmentation using deep learning on CT is faster and as accurate compared to manual segmentation.Eur Radiol. 2022 Jul;32(7):4780-4790. doi: 10.1007/s00330-022-08549-1. Epub 2022 Feb 10. Eur Radiol. 2022. PMID: 35142898
-
A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.J Am Soc Nephrol. 2022 Aug;33(8):1581-1589. doi: 10.1681/ASN.2021111400. Epub 2022 Jun 29. J Am Soc Nephrol. 2022. PMID: 35768178 Free PMC article.
-
Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.Nuklearmedizin. 2023 Dec;62(6):343-353. doi: 10.1055/a-2200-2145. Epub 2023 Nov 23. Nuklearmedizin. 2023. PMID: 37995707 Free PMC article. Review.
-
Artificial intelligence for body composition and sarcopenia evaluation on computed tomography: A systematic review and meta-analysis.Eur J Radiol. 2022 Apr;149:110218. doi: 10.1016/j.ejrad.2022.110218. Epub 2022 Feb 15. Eur J Radiol. 2022. PMID: 35183899
Cited by
-
Segmentation of ADPKD Computed Tomography Images with Deep Learning Approach for Predicting Total Kidney Volume.Biomedicines. 2025 Jan 22;13(2):263. doi: 10.3390/biomedicines13020263. Biomedicines. 2025. PMID: 40002677 Free PMC article.
-
CT-based radiomics: predicting early outcomes after percutaneous transluminal renal angioplasty in patients with severe atherosclerotic renal artery stenosis.Vis Comput Ind Biomed Art. 2024 Jan 12;7(1):1. doi: 10.1186/s42492-023-00152-5. Vis Comput Ind Biomed Art. 2024. PMID: 38212451 Free PMC article.
-
Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease.Investig Clin Urol. 2023 May;64(3):255-264. doi: 10.4111/icu.20220411. Investig Clin Urol. 2023. PMID: 37341005 Free PMC article.
-
Comparison of Vision Transformers and Convolutional Neural Networks in Medical Image Analysis: A Systematic Review.J Med Syst. 2024 Sep 12;48(1):84. doi: 10.1007/s10916-024-02105-8. J Med Syst. 2024. PMID: 39264388 Free PMC article.
-
Test Retest Reproducibility of Organ Volume Measurements in ADPKD Using 3D Multimodality Deep Learning.Acad Radiol. 2024 Mar;31(3):889-899. doi: 10.1016/j.acra.2023.09.009. Epub 2023 Oct 3. Acad Radiol. 2024. PMID: 37798206 Free PMC article.
References
-
- Harris PC. Autosomal dominant polycystic kidney disease: clues to pathogenesis. Hum Mol Genet. 1999;8:1861–1866. - PubMed
-
- Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol. 2006;1:64–69. - PubMed
-
- Chauveau D, Fakhouri F, Grünfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol. 2000;11:1767–1775. - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous